sotorasib,adagrasib
mirati,amgen
['adagrasib', 'codebreak 200', 'sotorasib']
looking forward to multiple major clinical updates tomorrow at #esmo22 on #kras-g12c inhibitors adagrasib &amp; sotorasib including codebreak 200 phase iii study. drugging kras cancers with allele-selective and pan-(k)ras drugs covered in our review 
Global Head of Cancer Research @Boehringer. Focus on improving the lives of cancer patients.